Assessing the risk of BRCA1-associated breast cancer using individual morphological criteria [1]

Histopathology

Volumn 38, Issue 4, 2001, Pages 378-384

  Jacquemier, J ^b   Lidereau, R ^a   Birnbaum, D ^b   Eisinger, F ^b   Sobol, H ^b  

^a INSERM   (France)

^b INSTITUT PAOLI CALMETTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CARCINOMA; CANCER RISK; CLINICAL FEATURE; CLINICAL PRACTICE; DISEASE ASSOCIATION; DISEASE COURSE; EVALUATION; FAMILY HISTORY; GENE MUTATION; GENETIC PREDISPOSITION; GENETIC RISK; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; MEDULLARY CARCINOMA; MOLECULAR BIOLOGY; MULTIVARIATE ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; SCREENING;

EID: 0035570330     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.2001.01131.x     Document Type: Letter

References (14)

1. Medullary carcinoma of the breast and BRCA1 mutation
2. The cytokeratin profile of medullary breast carcinoma of the breast
3. Histoprognostic grade in BRCAl-associated breast cancer
4. Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer
5. Hereditary breast cancer: Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage
6. Mutations at BRCAI: The medullary breast carcinoma revisited
7. Novel indications for BRCA1 screening using individual clinical and morphological features
8. Prophylactic mastectomy - The price of fear
9. Assessing the risk of breast cancer
10. Four years analysis of cancer genetic clinics activity in France from 1994 to 1997: A survey on 801 patients
11. Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients
12. Major improvement in the efficacy of BRCA1 mutation screening using morphoclinical features of breast cancer
13. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families
14. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews